Rapport

Global Market Study: HPV - April 2022

World Health Organization (WHO)

MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk for sustainable access to vaccine supply and define mitigating actions. This analysis focuses on HPV vaccines and was published in April 2022.

Auteurs

Langues

  • Anglais

Année de publication

2020

Éditeur

WHO

Type

Rapport

Catégories

  • Gestion de programme

Maladies

  • Papillomavirus humain

Mots-clés

  • MI4A
  • Planification, budgétisation et financement

Références sur le sujet

EPI-CORE-MI4A

TitreAuteurAnnéeTypeLangue
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportAnglais
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportAnglais
Global Market Study: HPV - April 2022World Health Organization (WHO)2020ReportAnglais
Global Market Study: Human Rabies vaccines - December 2020World Health Organization (WHO)2020ReportAnglais
Global Market Study: Measles-containing vaccines (MCV) - July 2020World Health Organization (WHO)2020ReportAnglais
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportAnglais
Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - June 2020World Health Organization (WHO)2020ReportAnglais
Global Market Study: Typhoid vaccines - 2020World Health Organization (WHO)2020ReportAnglais
MI4A Project OverviewWorld Health Organization (WHO)GuidanceAnglais
MI4A Vaccine Purchase DatabaseWorld Health Organization (WHO)DatasheetAnglais
Vaccine Price Report - 2017World Health Organization (WHO)2017ReportAnglais
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportAnglais

Ajouté par: Géraldine Nemrod

Ajouté le: 2021-01-30 08:00:22

Consultations: 1657

Liens

Ajouter une ressource